THE LATEST NEWS
LUNGevity and the American Lung Cancer Screening Initiative Form Partnership for Lung Cancer Awareness Month
Meet the College Students Raising Lung Cancer Awareness
LUNGevity is proud to be partnering with the American Lung Cancer Screening Initiative (ALCSI), a student-driven organization with 50 college chapters across the country, for Lung Cancer Awareness Month to help spread the message that anyone with lungs can get lung cancer.
We sat down with ALCSI executive director (and recent Rice University graduate) Priyanka Senthil to learn why these students care so much about raising awareness of lung cancer. Learn more about ALCSI and what to expect this November for Lung Cancer Awareness Month.
The International Lung Cancer Survivorship Conference (ILCSC) is almost here! On September 20-21, join us from the comfort of your home for an inspiring and educational experience you won’t want to miss. This is your entry to the latest breakthroughs in lung cancer research and care, with insights and discussions that span the globe.
Don’t Miss Out:
- Lung Cancer Basics: Get a head start on essential knowledge before the main event begins.
- Biomarker Breakouts: Engage directly with world-renowned leaders in the field and get your most pressing questions answered in real time.
- World-Class Experts: The agenda is packed with international lung cancer experts covering hot topics like early-stage lung cancer progress, advances in the treatment of small cell lung cancer, and cutting-edge precision medicine.
- Global Reach: New this year are breakout sessions in Mandarin Chinese and Spanish, an Indian breakout facilitated in English, and four global panel discussions covering Africa, Asia, Europe, and Latin America.
There is truly something for everyone at this year’s conference!
FDA Approves Two New Treatments for Lung Cancer
Research into better treatments for lung cancer continues to advance. In August, the United States Food and Drug Administration (FDA) approved two new regimens for the treatment of lung cancer:
New Chemotherapy-Free Treatment for Metastatic EGFR+ Lung Cancer
This new treatment option—the combination of lazertinib and amivantamab—is for people who are newly diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations.
New Immunotherapy Regimen for Resectable NSCLC
With this approval, patients with newly diagnosed, early-stage NSCLC have another option for perioperative treatment (treatment before and after surgery). Based on the results of the AEGEAN study, this regimen combines durvalumab with chemotherapy before surgery, followed by durvalumab alone after surgery.
This is great progress, and our work as a community is not done. LUNGevity continues to strategically support innovative research to help us fulfill our mission of transforming lung cancer into a curable disease.
Learn more about the research we are funding and how you can help.
Meet Marlys—a shining example of resilience and determination in our LUNGevity family! Diagnosed with stage IV non-small cell lung cancer in March 2023, Marlys faced her diagnosis head-on and inspired all those around her. Just two months after her diagnosis, she attended HOPE Summit with her daughter, Stephanie, and discovered Team LUNGevity. That spark ignited a family tradition.
The Carlsons first took on Grandma’s Marathon in Duluth, Minnesota in 2023 and returned, stronger than ever, in 2024. Marlys herself completed the 5K with her husband, Greg, while their children tackled the full marathon. In two years, Team Mini Mighty Marvelous Marlys has raised more than $26,000, with no signs of slowing down. Marlys and her family show us what it means to live fully and give back, even in the face of life’s toughest challenges.
Pictured: Marlys and her husband, Greg, celebrating after completing the William A. Irvin 5K on their 38th wedding anniversary.
Our Lung Health Resource Fair and Community Walks are where knowledge meets action—and we’re bringing them to Boston, Washington, DC, and New York City!
Take charge of your lung health and connect with a passionate community. Meet with local experts, enjoy wellness demonstrations and activities perfect for all ages and fitness levels, and make meaningful connections.
📅 Date: Saturday, October 26, 2024
🕘 Time: 9:00 am ET, with activities for all ages throughout the morning.
🏙️ Locations: Boston, DC, New York City (click the cities to learn more and register)
Don’t miss your chance to be part of this transformative experience. Whether you’re curious about lung health, supporting a loved one, or looking to make a difference, the Lung Health Resource Fair and Community Walks offer a unique way to engage, learn, and give back.
If you are not in Boston, DC, or NY, you can still join the movement to make a difference. Sign up for or create a Breathe Deep Anywhere event in your neighborhood today!
Exciting New Treatments for EGFR+ NSCLC on the Horizon
Thursday, October 10 | 12 pm ET
Join us for an interactive Facebook Live discussion on October 10 at 12pm ET to learn how immune cells can be engineered to target EGFR+ NSCLC. This webinar features Jill Feldman and Laura Book, members of the EGFR Resisters, and Dr. Alexandre Reuben from MD Anderson Cancer Center, a researcher engineering T cells to treat several types of lung cancer.
Jill Feldman,
EGFR Resisters
Laura Book,
EGFR Resisters
Dr. Alexandre Reuben,
MD Anderson
You can make your voice heard on policy priorities for the lung cancer community through the LUNGevity Action Network! It’s a quick and easy way to join in on lung cancer advocacy efforts across the country and in your own state. Our advocacy tool connects you directly with the right legislators and offers talking points that you can use as-is or customize to add your own experiences.
As Congress works to finalize appropriations for the coming fiscal year, we encourage advocates to write their legislators in support of the Lung Cancer Research Program at the Department of Defense, as well as the National Institutes of Health and National Cancer Institute. You can also urge your senators and representatives to support key legislation that will improve access to care on our Take Action page.
LUNGevity Partners with Black Health Matters for 3-Part Webinar Series
First webinar is September 19, 7 pm ET
Black Americans have poor health outcomes on nearly every disease index, being either at higher risk for developing an illness or dying from it in greater numbers. While access to health insurance and socioeconomic status play a significant part in these health disparities, many also lack awareness about a lot of preventive steps that could be taken for better health.
As part of our long-term partnership with Black Health Matters, we have scheduled a three-part webinar series to help raise awareness and educate the Black community about lung cancer by providing tips and resources for patients, caregivers, and the community at large.
Join us on Thursday, September 19, at 7 pm ET for first webinar of the series, “From Struggle to Strength: Empowering Black Patients on Their Lung Cancer Journey." This Gilead-sponsored session will feature a pulmonologist and an inspiring patient advocate who will share their story.
The other webinars are tentatively scheduled as follows:
October 17 - "Clearing the Air: Dispelling Myths and Providing Facts About Lung Cancer in Black Populations"
November 14 - “Breathing New Life: Empowering Black Patients in the Fight Against Lung Cancer”
Want to learn how drugs are approved? Check out this 3-part primer, created in partnership with the Rising Tide Foundation, to learn more about the FDA approval process.
IN CASE YOU MISSED IT
LUNGevity is transforming what it means to be diagnosed and live with lung cancer. Support our mission by making a tax-deductible donation today.
